John Thompson
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
John Craig Thompson is currently Chief Executive Officer & Director at Cerevance, Inc. since 2022 and Independent Non-Executive Director at NervGen Pharma Corp.
since 2022.
Former roles include President, Chief Executive Officer & Director at Anthera Pharmaceuticals, Inc. from 2016 to 2018; President & Chief Executive Officer at Neurana Pharmaceuticals, Inc.; Independent Director at Esperion Therapeutics, Inc. from 2025 to 2026; Vice President-Marketing at Pfizer Inc. from 2003 to 2010; Chief Operating Officer at Tetraphase Pharmaceuticals, Inc. from 2014 to 2015; and Chief Commercial Officer at Trius Therapeutics, Inc. Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NERVGEN PHARMA CORP. -.--% | 2025-05-16 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| NERVGEN PHARMA CORP. | Direktör/Styrelseledamot | 2022-04-13 |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Verkställande Direktör | 2022-04-01 |
| Företag | Position | Slut |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-07-13 |
| ANTHERA PHARMACEUTICALS, INC. | Verkställande Direktör | 2018-06-30 |
| TETRAPHASE PHARMACEUTICALS, INC. | Verksamhetschef | 2015-12-31 |
| PFIZER INC. | Försäljning & Marknadsföring | 2010-01-01 |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån